Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Management of white cataract using femtosecond laser-assisted cataract surgery (FLACS)

Search Title by author or title

Session Details

Session Title: Femtolaser-Assisted Cataract Surgery (FLACS) II

Session Date/Time: Monday 09/10/2017 | 08:30-10:30

Paper Time: 08:36

Venue: Room 4.4

First Author: : S.Chee SINGAPORE

Co Author(s): :    Y. Yang                    

Abstract Details


To report the outcome of a series of white cataracts managed with the aid of the femtosecond laser.


Singapore National Eye Centre


Retrospective review of consecutive white cataracts that underwent femtosecond laser assisted cataract surgery (FLACS) using Victus™ (Bausch+Lomb, Munich, Germany) at the Singapore National Eye Centre from June 2012 to Dec 2016. Data collected: patient demographics, type of white cataract, completeness of capsulotomy, best corrected visual acuity (BCVA) at 1 month and intraoperative complications. Outcome measures: capsulotomy completeness and integrity, fragmentation capability and BCVA at 1 month.


53 eyes of 50 patients underwent FLACS. Type of white cataracts were non-intumescent white (23 eyes), intumescent (25 eyes) and Morgagnian (5 eyes) cataracts. The capsulotomy was incomplete in 8 eyes (15.1%): 1/23 non-intumescent white cataracts, 3/25 intumescent cataracts and 4/5 Morgagnian cataracts. Nucleus fragmentation attempted in 38 eyes was effective in 9 eyes (23.7%) and partially effective in 14 eyes (44.7%). No anterior nor posterior capsule tears occurred. LogMAR visual acuity at 1 month was 0.07 (SD 0.09). The type of white cataract was the only risk factor identified for incomplete capsulotomy (Pearson Chi-Square 18.7, P<0.001).


Whilst the femtosecond laser enables the surgeon to safely create a capsulotomy in a white cataract, it is incomplete in 15.1%. The type of white cataract was identified as the main risk factor for capsulotomy incompleteness.

Financial Disclosure:

travel has been funded, fully or partially, by a competing company

Back to previous